Plain-English translation of NCT06822829 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks back at the medical records of people who were diagnosed with an aggressive type of blood cancer called diffuse large B-cell lymphoma (DLBCL) and then experienced a rare type of relapse where the cancer came back in a slower, less aggressive form. Researchers want to understand how often this unusual pattern happens, what the warning signs are, and which treatments work best for patients in this situation.
Most patients with this aggressive lymphoma relapse quickly with similarly aggressive disease. However, some patients experience a rare and puzzling situation where their cancer comes back in a slower form. Very little is known about this pattern because it's so uncommon, and there is no standard treatment plan for it. This study aims to fill that gap by learning from patients who have already gone through this experience.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records rather than asking you to attend new appointments or receive new treatments. If you are a living, contactable patient, you would be asked to sign a consent form allowing the research team to access and study your medical records, pathology reports, and clinical information from your initial diagnosis through your relapse and beyond. The study does not involve any new medications, procedures, or interventions—only a careful review of your medical history to understand your disease pattern.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy